Halo Collective Acquires Dissolve Medical

Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) is pleased to announce that it has acquired all of the issued and outstanding shares of 1000116327 Ontario Ltd. (dba Dissolve Medical) (“Dissolve Medical”). Dissolve Medical is the developer of CBD slits a precise, rapid, discreet and healthier option for cannabis consumption, consisting of strips containing CBD, CBN, or CBG formulations and owns proprietary recipes and all packaging and designs associated with the product. The CBD slits produce an oral delivery system, which are similar to breath strips, that can be used for energy elixirs, herbal remedies, and a smokeless alternative option to medical and recreational users of CBD, CBN, or CBG.

The acquisition was completed pursuant to a share exchange agreement among the Company and the sole shareholder of Dissolve Medical. In consideration for all of the issued and outstanding shares of Dissolve Medical, Halo issued an aggregate of 5,000,000 common shares in the capital of Halo (“Common Shares”).

The sole shareholder of Dissolve Medical has previously received Common Shares as a consultant and a finder in connection with previous unrelated transactions.